1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > China In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

China In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Summary

GlobalData’s new report, "China In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture", provides key market data on the China In Vitro Diagnostics market. The report provides value, in millions of US dollars within market segments - Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- In Vitro Diagnostics market includes Immuno Chemistry, Clinical Chemistry, Infectious Diagnostics, Haematology, Microbiology Culture, Histology and Cytology and Genetic Testing.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for In Vitro Diagnostics market.
- Global corporate-level profiles of key companies operating within the China In Vitro Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, Ortho-Clinical Diagnostics Inc. Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

China In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 14
2.1 What Is This Report About? 14
2.2 In Vitro Diagnostics Market Segmentation 14
2.3 Definitions of Markets Covered in the Report 17
3 In Vitro Diagnostics Market, China 30
3.1 In Vitro Diagnostics Market, China, Revenue ($m), 2007-2021 30
3.2 In Vitro Diagnostics Market, China, Revenue Mix ($m), 2014 32
3.3 In Vitro Diagnostics Market, China, Category Contribution by Revenue ($m), 2014 33
3.4 In Vitro Diagnostics Market, China, Category Comparison by Revenue ($m), 2007-2021 35
3.5 In Vitro Diagnostics Market, China, Revenue ($m), 2007-2014 37
3.6 In Vitro Diagnostics Market, China, Revenue ($m), 2014-2021 39
3.7 In Vitro Diagnostics Market, China, Company Share by Revenue ($m), 2014 41
4 Clinical Chemistry Market, China 43
4.1 Clinical Chemistry Market, China, Revenue Mix ($m), 2014 43
4.2 Clinical Chemistry Market, China, Segment Contribution (%), 2014 44
4.3 Clinical Chemistry Market, China, Revenue ($m), 2007-2014 46
4.4 Clinical Chemistry Market, China, Revenue ($m), 2014-2021 48
4.4.1 Clinical Chemistry Analyzers Market, China, Revenue ($m), by Segment, 2007-2014 50
4.4.2 Therapeutic Drug Monitoring Market, China, Revenue ($m), by Segment, 2007-2014 52
4.4.3 Urine Analysis Market, China, Revenue ($m), by Segment, 2007-2014 54
4.4.4 Clinical Chemistry Analyzers Market, China, Revenue ($m), by Segment, 2014-2021 56
4.4.5 Therapeutic Drug Monitoring Market, China, Revenue ($m), by Segment, 2014-2021 58
4.4.6 Urine Analysis Market, China, Revenue ($m), by Segment, 2014-2021 60
4.5 Clinical Chemistry Market, China, Distribution Share by Revenue ($m), 2013-2014 62
4.6 Clinical Chemistry Market, China, Company Share by Revenue ($m), 2014 63
5 Genetic Testing Market, China 65
5.1 Genetic Testing Market, China, Revenue Mix ($m), 2014 65
5.2 Genetic Testing Market, China, Segment Contribution (%), 2014 66
5.3 Genetic Testing Market, China, Revenue ($m), 2007-2014 67
5.4 Genetic Testing Market, China, Revenue ($m), 2014-2021 69
5.5 Genetic Testing Market, China, Distribution Share by Revenue ($m), 2013-2014 71
5.6 Genetic Testing Market, China, Company Share by Revenue ($m), 2014 72
6 Haematology Market, China 74
6.1 Haematology Market, China, Revenue Mix ($m), 2014 74
6.2 Haematology Market, China, Segment Contribution (%), 2014 75
6.3 Haematology Market, China, Revenue ($m), 2007-2014 76
6.4 Haematology Market, China, Revenue ($m), 2014-2021 78
6.4.1 Haematology Cell Counters Market, China, Revenue ($m), by Segment, 2007-2014 80
6.4.2 Haematology Rapid Tests and POC Market, China, Revenue ($m), by Segment, 2007-2014 82
6.4.3 Haematology Reagents Market, China, Revenue ($m), by Segment, 2007-2014 84
6.4.4 Haemostasis Market, China, Revenue ($m), by Segment, 2007-2014 86
6.4.5 Immunohaematology Market, China, Revenue ($m), by Segment, 2007-2014 88
6.4.6 Haematology Cell Counters Market, China, Revenue ($m), by Segment, 2014-2021 90
6.4.7 Haematology Rapid Tests and POC Market, China, Revenue ($m), by Segment, 2014-2021 92
6.4.8 Haematology Reagents Market, China, Revenue ($m), by Segment, 2014-2021 94
6.4.9 Haemostasis Market, China, Revenue ($m), by Segment, 2014-2021 96
6.4.10 Immunohaematology Market, China, Revenue ($m), by Segment, 2014-2021 98
6.5 Haematology Market, China, Distribution Share by Revenue ($m), 2013-2014 100
6.6 Haematology Market, China, Company Share by Revenue ($m), 2014 101
7 Histology And Cytology Market, China 103
7.1 Histology And Cytology Market, China, Revenue Mix ($m), 2014 103
7.2 Histology And Cytology Market, China, Segment Contribution (%), 2014 104
7.3 Histology And Cytology Market, China, Revenue ($m), 2007-2014 105
7.4 Histology And Cytology Market, China, Revenue ($m), 2014-2021 107
7.5 Histology And Cytology Market, China, Distribution Share by Revenue ($m), 2013-2014 109
7.6 Histology And Cytology Market, China, Company Share by Revenue ($m), 2014 110
8 Immuno Chemistry Market, China 112
8.1 Immuno Chemistry Market, China, Revenue Mix ($m), 2014 112
8.2 Immuno Chemistry Market, China, Segment Contribution (%), 2014 113
8.3 Immuno Chemistry Market, China, Revenue ($m), 2007-2014 115
8.4 Immuno Chemistry Market, China, Revenue ($m), 2014-2021 117
8.4.1 Anemia Tests Market, China, Revenue ($m), by Segment, 2007-2014 119
8.4.2 Disease Specific Immunochemistry Market, China, Revenue ($m), by Segment, 2007-2014 121
8.4.3 Endocrinology Tests Market, China, Revenue ($m), by Segment, 2007-2014 123
8.4.4 IgE Allergy Blood Tests Market, China, Revenue ($m), by Segment, 2007-2014 125
8.4.5 Immunochemistry Analyzers Market, China, Revenue ($m), by Segment, 2007-2014 127
8.4.6 Immunochemistry Rapid Tests and POC Market, China, Revenue ($m), by Segment, 2007-2014 129
8.4.7 Vitamins Tests Market, China, Revenue ($m), by Segment, 2007-2014 131
8.4.8 Anemia Tests Market, China, Revenue ($m), by Segment, 2014-2021 133
8.4.9 Disease Specific Immunochemistry Market, China, Revenue ($m), by Segment, 2014-2021 135
8.4.10 Endocrinology Tests Market, China, Revenue ($m), by Segment, 2014-2021 137
8.4.11 IgE Allergy Blood Tests Market, China, Revenue ($m), by Segment, 2014-2021 139
8.4.12 Immunochemistry Analyzers Market, China, Revenue ($m), by Segment, 2014-2021 141
8.4.13 Immunochemistry Rapid Tests and POC Market, China, Revenue ($m), by Segment, 2014-2021 143
8.4.14 Vitamins Tests Market, China, Revenue ($m), by Segment, 2014-2021 145
8.5 Immuno Chemistry Market, China, Distribution Share by Revenue ($m), 2013-2014 147
8.6 Immuno Chemistry Market, China, Company Share by Revenue ($m), 2014 148
9 Infectious Diagnostics Market, China 150
9.1 Infectious Diagnostics Market, China, Revenue Mix ($m), 2014 150
9.2 Infectious Diagnostics Market, China, Segment Contribution (%), 2014 151
9.3 Infectious Diagnostics Market, China, Revenue ($m), 2007-2014 153
9.4 Infectious Diagnostics Market, China, Revenue ($m), 2014-2021 155
9.4.1 Infectious Diagnostics Rapid Tests and POC Market, China, Revenue ($m), by Segment, 2007-2014 157
9.4.2 Infectious Diagnostics Rapid Tests and POC Market, China, Revenue ($m), by Segment, 2014-2021 159
9.5 Infectious Diagnostics Market, China, Distribution Share by Revenue ($m), 2013-2014 161
9.6 Infectious Diagnostics Market, China, Company Share by Revenue ($m), 2014 162
10 Microbiology Culture Market, China 164
10.1 Microbiology Culture Market, China, Revenue Mix ($m), 2014 164
10.2 Microbiology Culture Market, China, Segment Contribution (%), 2014 165
10.3 Microbiology Culture Market, China, Revenue ($m), 2007-2014 167
10.4 Microbiology Culture Market, China, Revenue ($m), 2014-2021 169
10.4.1 Microbiology Analyzers Market, China, Revenue ($m), by Segment, 2007-2014 171
10.4.2 Microbiology Analyzers Market, China, Revenue ($m), by Segment, 2014-2021 173
10.5 Microbiology Culture Market, China, Distribution Share by Revenue ($m), 2013-2014 175
10.6 Microbiology Culture Market, China, Company Share by Revenue ($m), 2014 176
11 Overview of Key Companies in China, In Vitro Diagnostics Market 178
11.1 Siemens Healthcare 178
11.1.1 Company Overview 178
11.2 F. Hoffmann-La Roche Ltd. 178
11.2.1 Company Overview 178
11.3 Danaher Corporation 178
11.3.1 Company Overview 178
11.4 Abbott Laboratories 179
11.4.1 Company Overview 179
11.5 Sysmex Corporation 179
11.5.1 Company Overview 179
11.6 Becton, Dickinson and Company 179
11.6.1 Company Overview 179
11.7 Bio-Rad Laboratories, Inc. 179
11.7.1 Company Overview 179
11.8 Mindray Medical International Limited 180
11.8.1 Company Overview 180
11.9 bioMerieux S.A. 180
11.9.1 Company Overview 180
11.10 Thermo Fisher Scientific Inc. 180
11.10.1 Company Overview 180
11.11 Ortho-Clinical Diagnostics Inc. 181
11.11.1 Company Overview 181
11.12 Nihon Kohden Corporation 181
11.12.1 Company Overview 181
11.13 Alere Inc. 181
11.13.1 Company Overview 181
11.14 Denka Seiken Co., Ltd. 182
11.14.1 Company Overview 182
12 In Vitro Diagnostics Market Pipeline Products 183
13 Financial Deals Landscape 189
13.1 Acquisition 189
13.1.1 Zhejiang Hisun Pharma to Acquire 33% Stake in Zhejiang-based Medical Apparatus and Instruments Company for USD2.3 Million 189
13.1.2 Hangzhou Century to Acquire Ewell for USD178 Million 190
13.1.3 Beihai Yinhe to Acquire 60% Stake in Jiangsu Decon Bio-Sci-Tech for USD29.4 Million 191
13.1.4 Beijing Leadman Biochemistry Plans to Acquire Stakes in Shanghai Units of DiaSys Diagnostic Systems for USD55.4 Million 192
13.2 Debt Offerings 193
13.2.1 Lepu Medical Technology Plans to Raise USD187.1 Million in Private Placement of Notes 193
13.3 Equity Offerings 194
13.3.1 Guangzhou Improve Medical Instruments Raises USD7.4 Million in Public Offering of Shares 194
13.3.2 Lepu Medical Technology to Raise USD200.8 Million in Private Placement of Shares 195
13.3.3 Guangzhou Wondfo Biotech Raises USD57.5 Million in IPO 196
13.3.4 Lepu Medical Amends Terms of Private Placement of Shares for USD208 Million 197
13.3.5 Beijing Strong Biotech Prices IPO for USD57 Million 198
13.3.6 Beijing Leadman Biochemistry Plans to Raise USD18.5 Million in Private Placement 199
13.4 Partnerships 200
13.4.1 Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 200
13.4.2 Seegene Enters into Co-Development Agreement with BD Life Sciences 201
13.4.3 OriGene Technologies Enters into Licensing Agreement with Diadexus 202
13.4.4 MdxHealth Enters into Licensing Agreement with Erasmus MC 203
13.4.5 Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 204
13.4.6 Sigma-Aldrich Enters into Distribution Agreement with LGC 205
13.4.7 OvaGene Oncology Enters into Agreement with Etta Healthcare 206
13.4.8 Shuwen Biotech Enters into Agreement with Jiangsu Hengrui Medicine 207
13.4.9 InTouch Health Enters into Agreement with iSchemaView 208
13.4.10 DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics 209
13.4.11 Shanghai Runda to Form Joint Venture with Sinopharm 210
13.4.12 Illumina Enters into Co-Development Agreement with Annoroad Gene Technology 211
13.4.13 WuXi AppTec Enters into Agreement with Fudan University 212
13.4.14 Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 213
13.4.15 Livzon Pharma to Form Joint Venture with Cynvenio Biosystems 214
13.4.16 Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 215
13.4.17 Shanghai Lidebiotech Enters into Agreement with Clearbridge BioMedics 216
13.4.18 DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 217
13.4.19 IncellDx Enters into Licensing Agreement with Claremont BioSolutions 218
13.4.20 Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 219
13.4.21 AngioDynamics Enters into Licensing Agreement with EmboMedics 220
13.4.22 Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 221
13.4.23 Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology 222
13.4.24 Biocartis Enters into Licensing and Development Agreement with Microbiome 223
13.4.25 CBScientific Enters into Distribution Agreement with UTest 224
13.4.26 GeneThera Enters into Co-Development Agreement with Hudson Robotics 225
13.4.27 Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 226
13.4.28 Axis-Shield Enters into Licensing Agreement with Hangzhou Joinstar Biomedical 227
13.4.29 Genomic Vision Extends Agreement with Quest Diagnostics 228
13.4.30 Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 229
13.4.31 Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 231
13.4.32 BioMerieux Enters into Licensing Agreement with Astute Medical 232
13.4.33 MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 233
13.4.34 NoemaLife Enters into Distribution Agreement with Horiba Medical 234
13.4.35 Akers Biosciences Forms Joint Venture with Hainan Savy Investment Management 235
13.4.36 Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech 236
13.4.37 Enigma Diagnostics Forms Joint Venture with Beijing Leadman Biochemistry 237
13.4.38 Clinical Genomics Enters into Licensing Agreement with CSIRO 238
13.4.39 Hangzhou Joinstar Biomedical Enters into Co-Development Agreement with Response Biomedical 239
13.5 Private Equity 240
13.5.1 Mindray Medical Receives Revised Non-Binding Going Private Proposal from Li Xiting, Xu Hang and Cheng Minghe 240
13.6 Venture Financing 241
13.6.1 CANbridge Life Sciences Raises USD10 Million in Series A Venture Financing 241
14 Recent Developments 242
14.1 Corporate Communications 242
14.1.1 Jun 30, 2015: Shuwen Biotech Appoints Recognized Leader in Urologic Pathology to Advisory Board 242
14.1.2 Jun 15, 2015: OmniVision Launches Ultra-Compact, Cost-Effective CameraChip Sensor for Advanced Medical Imaging 242
14.1.3 Jun 08, 2015: Celator Pharmaceuticals Announces Expansion of Clinical Study in Patients with Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia at High-Risk of Treatment-Related Mortality 243
14.1.4 Jun 04, 2015: World Glaucoma Congress to Feature Symposium on XEN Gel Stent for Minimally Invasive IOP Reduction 244
14.1.5 Apr 15, 2015: PerkinElmer Launches First Fully Automated Genetic Disorder Screening System in China 245
14.1.6 Feb 25, 2015: Diagnostic Industry Veteran Gregory C. Critchfield Joins Shuwen Biotech's Advisory Board 246
14.1.7 Jan 27, 2015: Agilent Gets Chinese Approval For SureScan Dx Microarray Scanner 246
14.1.8 Dec 04, 2014: Neogen names COO 247
14.2 Financial Announcements 248
14.2.1 Sep 28, 2015: Synthetic Biologics Initiates SYN-004 Phase 2b Proof-of-Concept Clinical Trial 248
14.2.2 Aug 10, 2015: Mindray Announces Second Quarter 2015 Financial Results 251
14.2.3 Jul 21, 2015: Neogen reports record revenues and earnings 253
14.2.4 May 11, 2015: Mindray Announces First Quarter 2015 Financial Results 255
14.2.5 May 09, 2015: Shanghai MicroPort Orthopedics Hosts First SuperPath Online Symposium 257
14.2.6 Apr 20, 2015: Pluristem's Clinical Advisory Board Prepares Phase II Clinical Trials in Critical Limb Ischemia in Europe and Japan 258
14.2.7 Mar 26, 2015: Neogen reports 13% increase in net income 258
14.2.8 Mar 09, 2015: Mindray Announces 2014 Fourth Quarter and Full Year Results 260
14.2.9 Mar 04, 2015: Novacyt and Leica Biosystems Sign Major Distribution Deal for NOVAprep in Greater China 263
14.2.10 Jan 12, 2015: Mindray Announces Preliminary 2014 Operating Results and 2015 Net Revenues Guidance 264
14.2.11 Dec 31, 2014: MicroPort Completes First Implantation of Reewarm18 265
14.2.12 Dec 18, 2014: Neogen reports 26% increase in net income 267
14.2.13 Nov 03, 2014: Mindray Announces Third Quarter 2014 Financial Results 268
14.2.14 Oct 29, 2014: KHB Announces 2014 Third Quarter Report 271
14.2.15 Oct 10, 2014: Edan Introduces Acclarix Compact Ultrasound System at ANESTHESIOLOGY2014 271
14.3 Government and Public Interest 273
14.3.1 Oct 15, 2014: Mindray Medical to Exhibit New Products at Upcoming Medical Equipment Fairs 273
14.4 Legal And Regulatory 274
14.4.1 Dec 11, 2014: Shuwen Biotech Receives License to Operate New Diagnostic Reference Lab in China and Forms New Subsidiary for the Lab 274
14.5 Other Significant Developments 274
14.5.1 Jun 11, 2015: Lansen subsidiary signs a distribution agreement with Bio-Rad China and expands into the clinical diagnostic market in the PRC 274
14.5.2 Feb 12, 2015: Mindray Signs Contract with Kenyan Government to Facilitate National Healthcare Project 275
14.5.3 Feb 06, 2015: Response Biomedical Announces Expansion of Chinese Distribution Agreement for RAMP Cardiovascular Products 275
14.5.4 Dec 09, 2014: Fred Hutch, China partner to collect samples of all types of cancer 276
14.5.5 Oct 20, 2014: Pressure BioSciences Announces Partnership with Powertech Technology Company Ltd. to Develop China Market for PBI's PCT Platform 277
14.6 Product News 278
14.6.1 Jul 27, 2015: CBMG Announces Successful New Certifications for Proprietary Cell and Tissue Preservation Media Kits 278
14.6.2 Jul 09, 2015: BioNano Genomics Announces Addition of Gene Company as China Mainland and HK/Macau Distributor 279
14.7 Strategy And Business Planning 279
14.7.1 Sep 16, 2015: WuXi NextCODE and Fudan Children's Hospital Partner to Lead Whole Genome Diagnostics for Rare Diseases in China 279
14.7.2 Sep 01, 2015: Agena Bioscience Opens Office in Shanghai, China 280
14.7.3 Jun 23, 2015: SGS Life Science Services Completes New Laboratories At Its Shanghai Facility 281
14.7.4 Jan 19, 2015: PerkinElmer Opens New Medical Laboratory in Suzhou, China 281
14.7.5 Jan 09, 2015: Meridian Opens a New Office in Beijing, China 282
14.7.6 Oct 30, 2014: Irvine Pharmaceutical Services Announces The Opening Of An Analytical Facility In Hangzhou, China 282
14.7.7 Oct 30, 2014: Sartorius Opens New Application Center in Shanghai 283
14.7.8 Oct 22, 2014: Gerresheimer Opens Its First Development Center In China 283
15 Appendix 285
15.1 Research Methodology 286
15.1.1 Coverage 286
15.1.2 Secondary Research 286
15.1.3 Primary Research 286
15.1.4 Company Share Analysis 287
15.1.5 Distribution Share Analysis 287
15.2 GlobalData Consulting 287
15.3 Contact Us 287
15.4 Disclaimer 288

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, China, Revenue ($m), USD Constant, 2007-2021 31
Table 2: In Vitro Diagnostics Market, China, Category Contribution by Revenue ($m), 2014 34
Table 3: In Vitro Diagnostics Market, China, Category Comparison by Revenue ($m), USD Constant, 2007-2021 36
Table 4: In Vitro Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 38
Table 5: In Vitro Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 40
Table 6: In Vitro Diagnostics Market, China, Company Share by Revenue ($m), USD Constant, 2014 42
Table 7: Clinical Chemistry Market, China, Segment Contribution (%), 2014 45
Table 8: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 47
Table 9: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 49
Table 10: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 51
Table 11: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 53
Table 12: Urine Analysis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 55
Table 13: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 57
Table 14: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 59
Table 15: Urine Analysis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 61
Table 16: Clinical Chemistry Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014 62
Table 17: Clinical Chemistry Market, China, Company Share by Revenue ($m), USD Constant, 2014 64
Table 18: Genetic Testing Market, China, Segment Contribution (%), 2014 66
Table 19: Genetic Testing Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 68
Table 20: Genetic Testing Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 70
Table 21: Genetic Testing Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014 71
Table 22: Genetic Testing Market, China, Company Share by Revenue ($m), USD Constant, 2014 73
Table 23: Haematology Market, China, Segment Contribution (%), 2014 75
Table 24: Haematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 77
Table 25: Haematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 79
Table 26: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 81
Table 27: Haematology Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 83
Table 28: Haematology Reagents Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 85
Table 29: Haemostasis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 87
Table 30: Immunohaematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 89
Table 31: Haematology Cell Counters Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 91
Table 32: Haematology Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 93
Table 33: Haematology Reagents Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 95
Table 34: Haemostasis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 97
Table 35: Immunohaematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 99
Table 36: Haematology Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014 100
Table 37: Haematology Market, China, Company Share by Revenue ($m), USD Constant, 2014 102
Table 38: Histology And Cytology Market, China, Segment Contribution (%), 2014 104
Table 39: Histology And Cytology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 106
Table 40: Histology And Cytology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 108
Table 41: Histology And Cytology Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014 109
Table 42: Histology And Cytology Market, China, Company Share by Revenue ($m), USD Constant, 2014 111
Table 43: Immuno Chemistry Market, China, Segment Contribution (%), 2014 114
Table 44: Immuno Chemistry Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 116
Table 45: Immuno Chemistry Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 118
Table 46: Anemia Tests Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 120
Table 47: Disease Specific Immunochemistry Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 122
Table 48: Endocrinology Tests Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 124
Table 49: IgE Allergy Blood Tests Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 126
Table 50: Immunochemistry Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 128
Table 51: Immunochemistry Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 130
Table 52: Vitamins Tests Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 132
Table 53: Anemia Tests Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 134
Table 54: Disease Specific Immunochemistry Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 136
Table 55: Endocrinology Tests Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 138
Table 56: IgE Allergy Blood Tests Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 140
Table 57: Immunochemistry Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 142
Table 58: Immunochemistry Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 144
Table 59: Vitamins Tests Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 146
Table 60: Immuno Chemistry Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014 147
Table 61: Immuno Chemistry Market, China, Company Share by Revenue ($m), USD Constant, 2014 149
Table 62: Infectious Diagnostics Market, China, Segment Contribution (%), 2014 152
Table 63: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 154
Table 64: Infectious Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 156
Table 65: Infectious Diagnostics Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 158
Table 66: Infectious Diagnostics Rapid Tests and POC Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 160
Table 67: Infectious Diagnostics Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014 161
Table 68: Infectious Diagnostics Market, China, Company Share by Revenue ($m), USD Constant, 2014 163
Table 69: Microbiology Culture Market, China, Segment Contribution (%), 2014 166
Table 70: Microbiology Culture Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 168
Table 71: Microbiology Culture Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 170
Table 72: Microbiology Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 172
Table 73: Microbiology Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 174
Table 74: Microbiology Culture Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014 175
Table 75: Microbiology Culture Market, China, Company Share by Revenue ($m), USD Constant, 2014 177
Table 76: In Vitro Diagnostics Market Pipeline Products 183
Table 77: Zhejiang Hisun Pharma to Acquire 33% Stake in Zhejiang-based Medical Apparatus and Instruments Company for USD2.3 Million 189
Table 78: Hangzhou Century to Acquire Ewell for USD178 Million 190
Table 79: Beihai Yinhe to Acquire 60% Stake in Jiangsu Decon Bio-Sci-Tech for USD29.4 Million 191
Table 80: Beijing Leadman Biochemistry Plans to Acquire Stakes in Shanghai Units of DiaSys Diagnostic Systems for USD55.4 Million 192
Table 81: Lepu Medical Technology Plans to Raise USD187.1 Million in Private Placement of Notes 193
Table 82: Guangzhou Improve Medical Instruments Raises USD7.4 Million in Public Offering of Shares 194
Table 83: Lepu Medical Technology to Raise USD200.8 Million in Private Placement of Shares 195
Table 84: Guangzhou Wondfo Biotech Raises USD57.5 Million in IPO 196
Table 85: Lepu Medical Amends Terms of Private Placement of Shares for USD208 Million 197
Table 86: Beijing Strong Biotech Prices IPO for USD57 Million 198
Table 87: Beijing Leadman Biochemistry Plans to Raise USD18.5 Million in Private Placement 199
Table 88: Curetis Enters into Licensing Agreement with Acumen Research Labs for AcuSept 200
Table 89: Seegene Enters into Co-Development Agreement with BD Life Sciences 201
Table 90: OriGene Technologies Enters into Licensing Agreement with Diadexus 202
Table 91: MdxHealth Enters into Licensing Agreement with Erasmus MC 203
Table 92: Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 204
Table 93: Sigma-Aldrich Enters into Distribution Agreement with LGC 205
Table 94: OvaGene Oncology Enters into Agreement with Etta Healthcare 206
Table 95: Shuwen Biotech Enters into Agreement with Jiangsu Hengrui Medicine 207
Table 96: InTouch Health Enters into Agreement with iSchemaView 208
Table 97: DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics 209
Table 98: Shanghai Runda to Form Joint Venture with Sinopharm 210
Table 99: Illumina Enters into Co-Development Agreement with Annoroad Gene Technology 211
Table 100: WuXi AppTec Enters into Agreement with Fudan University 212
Table 101: Halozyme Therapeutics Enters into Co-Development Agreement with Ventana Medical Systems for Cancer Treatment 213
Table 102: Livzon Pharma to Form Joint Venture with Cynvenio Biosystems 214
Table 103: Courtagen Life Sciences Enter into Distribution Agreement with Pronto Diagnostics for Next Generation Sequencing Tests 215
Table 104: Shanghai Lidebiotech Enters into Agreement with Clearbridge BioMedics 216
Table 105: DiaCarta Enters into Licensing Agreement with University of Potsdam for Colon Cancer Test 217
Table 106: IncellDx Enters into Licensing Agreement with Claremont BioSolutions 218
Table 107: Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 219
Table 108: AngioDynamics Enters into Licensing Agreement with EmboMedics 220
Table 109: Ion Beam Applications Enters into Distribution Agreement with Toshiba Medical Systems 221
Table 110: Applied BioCode Expands Licensing Agreement with PerkinElmer for Barcoded Magnetic Bead Technology 222
Table 111: Biocartis Enters into Licensing and Development Agreement with Microbiome 223
Table 112: CBScientific Enters into Distribution Agreement with UTest 224
Table 113: GeneThera Enters into Co-Development Agreement with Hudson Robotics 225
Table 114: Nanospeed Enters into Distribution Agreement with DiaSys for Test4D 226
Table 115: Axis-Shield Enters into Licensing Agreement with Hangzhou Joinstar Biomedical 227
Table 116: Genomic Vision Extends Agreement with Quest Diagnostics 228
Table 117: Ortho-Clinical Enters into Distribution Agreement with Quotient for MosaiQ 229
Table 118: Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 231
Table 119: BioMerieux Enters into Licensing Agreement with Astute Medical 232
Table 120: MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 233
Table 121: NoemaLife Enters into Distribution Agreement with Horiba Medical 234
Table 122: Akers Biosciences Forms Joint Venture with Hainan Savy Investment Management 235
Table 123: Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech 236
Table 124: Enigma Diagnostics Forms Joint Venture with Beijing Leadman Biochemistry 237
Table 125: Clinical Genomics Enters into Licensing Agreement with CSIRO 238
Table 126: Hangzhou Joinstar Biomedical Enters into Co-Development Agreement with Response Biomedical 239
Table 127: Mindray Medical Receives Revised Non-Binding Going Private Proposal from Li Xiting, Xu Hang and Cheng Minghe 240
Table 128: CANbridge Life Sciences Raises USD10 Million in Series A Venture Financing 241

1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, China, Revenue ($m), USD Constant, 2007-2021 30
Figure 2: In Vitro Diagnostics Market, China, Revenue Mix ($m), 2014 32
Figure 3: In Vitro Diagnostics Market, China, Category Contribution (%), 2014 33
Figure 4: In Vitro Diagnostics Market, China, Category Comparison by Revenue ($m), USD Constant, 2007-2021 35
Figure 5: In Vitro Diagnostics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 37
Figure 6: In Vitro Diagnostics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 39
Figure 7: In Vitro Diagnostics Market, China, Company Share (%) 2014 41
Figure 8: Clinical Chemistry Market, China, Revenue Mix ($m), 2014 43
Figure 9: Clinical Chemistry Market, China, Segment Contribution (%), 2014 44
Figure 10: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 46
Figure 11: Clinical Chemistry Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 48
Figure 12: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 50
Figure 13: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 52
Figure 14: Urine Analysis Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 54
Figure 15: Clinical Chemistry Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Figure 16: Therapeutic Drug Monitoring Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 58
Figure 17: Urine Analysis Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 60
Figure 18: Clinical Chemistry Market, China, Company Share (%) 2014 63
Figure 19: Genetic Testing Market, China, Revenue Mix ($m), 2014 65
Figure 20: Genetic Testing Market, China, Segment Contribution (%), 2014 66
Figure 21: Genetic Testing Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 67
Figure 22: Genetic Testing Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 69
Figure 23: Genetic Testing Market, China, Company Share (%) 2014 72
Figure 24: Haematology Market, China, Revenue Mix ($m), 2014 74
Figure 25: Haematology Market, China, Segment Contribution (%), 2014 75
Figure 26: Haematology Market, China, Revenue ($m), USD Constant, Historic, 2007-2014 76
Figure 27: Haematology Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021 78
Figure 28: Haematology Cell Counters Market, China, Revenue ($m), USD Constant,

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.